Cresco Labs Inc. (CSE:CL)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	341	460	609	739	2,439	2,984
Market Cap Growth	-66.96%	-24.45%	-17.57%	-69.69%	-18.25%	144.18%
Enterprise Value	888	1,062	1,293	1,465	2,935	3,452
Last Close Price	0.96	1.32	1.79	2.45	8.39	12.55
Forward PE	-	-	-	-	28.83	117.25
PS Ratio	0.37	0.45	0.61	0.66	2.39	5.06
PB Ratio	0.69	0.82	1.08	0.93	2.42	4.07
P/FCF Ratio	2.78	2.83	145.16	-	-	-
P/OCF Ratio	2.12	2.42	7.88	29.15	133.05	-
EV/Sales Ratio	0.95	1.03	1.30	1.31	2.88	5.85
EV/EBITDA Ratio	3.51	4.32	7.64	9.32	14.98	203.79
EV/EBIT Ratio	7.32	6.60	14.94	16.86	19.96	-
EV/FCF Ratio	7.24	6.54	307.88	-	-	-
Debt / Equity Ratio	1.75	1.65	1.60	1.14	0.78	0.65
Debt / EBITDA Ratio	3.51	3.20	4.24	4.35	3.38	10.67
Debt / FCF Ratio	7.02	5.66	214.77	-	-	-
Asset Turnover	0.50	0.53	0.51	0.49	0.54	0.50
Inventory Turnover	3.75	3.77	3.37	3.17	3.69	4.33
Quick Ratio	1.84	2.01	0.77	0.69	0.93	0.66
Current Ratio	3.11	3.12	1.39	1.27	1.46	0.99
Return on Equity (ROE)	-9.89%	-14.82%	-35.41%	-31.16%	-43.24%	-20.66%
Return on Assets (ROA)	4.11%	5.16%	2.78%	2.39%	4.82%	-1.25%
Return on Capital (ROIC)	5.42%	6.54%	3.46%	3.00%	6.12%	-1.69%
Return on Capital Employed (ROCE)	7.10%	8.90%	5.70%	4.80%	7.80%	-
Earnings Yield	-18.25%	-23.26%	-38.04%	-38.81%	-16.58%	-4.36%
FCF Yield	35.92%	35.31%	0.69%	-11.77%	-4.12%	-4.06%
Buyback Yield / Dilution	-2.67%	-6.69%	-8.61%	-13.66%	-24.64%	-77.88%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.